"Right now, policy developments in Washington, D.C., are placing our rural North Dakota hospitals and other health care providers at significant risk of shutting down, choking off health care access for thousands of patients in rural communities who have few other options. Last month, an agency...
"A group of about 50 protesters picketed in front of U.S. Rep. Larry Bucshon’s Terre Haute district office Thursday morning to denounce his recent introduction of legislation they say could harm drug discounts and limit safety net providers. The protesters, many from Austin, Indiana, are part...
"Drive any stretch of highway in North Dakota, and one is struck by the beauty of this state. Still, the freedom we feel when we travel our endless prairies reveals a stark truth: North Dakota has a health care access problem. It’s certainly no secret that...
"A double whammy of federal budget cuts might force many hospitals, particularly those that serve poor or rural communities, to scale back services or even shut their doors. The $3.6 billion in cuts this year—$2 billion from a program that sends federal dollars to hospitals that...
"High drug prices were a hot topic of discussion at HHS secretary nominee Alex Azar's Senate confirmation hearing Tuesday, reports USA Today. Here are four things to know about Mr. Azar's stance on drug prices: 1. He agrees drug prices are too high. Sen. Ron Wyden, D-Ore., cited numerous drugs...
"340B Drug Pricing Program advocates from the AIDS Healthcare Foundation (AHF) stepped up their criticism of Congressional leaders following the release yesterday of a hit-piece from the House Energy and Commerce Committee masquerading as a so-called investigation. “This biased report was bought and paid for by big drug companies...
"Drive any stretch of highway in North Dakota, and one is struck by the beauty of this state. Still, the freedom we feel when we travel our endless prairies reveals a stark truth: North Dakota has a health care access problem. It's certainly no secret that...
"Now that a U.S. District Court has postponed the hospital industry's legal challenge to cutbacks in the 340B drug discount program, it falls to Congress to reverse the Trump administration's egregious new rules. Believe it or not, there's hope, since the new rules benefit no one—quite...
"It’s not easy to get Americans mad at a behind-the-scenes industry they’ve barely even heard of, but pharmaceutical companies have spent most of this year trying. “Who decides what you pay for your medicines? Not who you might think,” a concerned woman’s voice says in a radio spot airing in the...
"As you and your readers may now be aware, the 340B Drug Pricing Program has been under siege for the past couple months. The program requires drug manufacturers to provide outpatient drugs to eligible health care organizations at significantly reduced prices, so that those savings...
